Fig. 5From: Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s diseaseImmunofluorescent staining of CHCHD2 and α-synuclein in different areas of mouse brain slices. a and b Decreased CHCHD2 (green) and increased α-synuclein (blue) in substantia nigra (***p < 0.001, ##p < 0.01, Mann–Whitney U test, n = 3). c and d Decreased CHCHD2 (green) and increased α-synuclein (blue) in rest of midbrain (**p < 0.01, ##p < 0.01, Mann–Whitney U test, n = 3). e and f Decreased CHCHD2 (green) and increased α-synuclein (blue) in frontal cortex (***p < 0.001, ##p < 0.01, Mann–Whitney U test, n = 3). g and h Decreased CHCHD2 (green) and increased α-synuclein (blue) in cerebellum (***p < 0.001, #p < 0.05, Mann–Whitney U test, n = 3). Scale bar: 10 μmBack to article page